These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 31075509)
41. Clinical Risk Factors for Infective Endocarditis in Salvador VB; Chapagain B; Joshi A; Brennessel DJ Tex Heart Inst J; 2017 Feb; 44(1):10-15. PubMed ID: 28265207 [TBL] [Abstract][Full Text] [Related]
42. In vitro activity of daptomycin and comparator agents against Staphylococcus aureus isolates from intravenous drug users with right endocarditis. Sanchez-Porto A; Casanova-Roman M; Casas-Ciria J; Santaella MJ; Sanchez-Morenilla I; Eiros-Bouza JM Infez Med; 2010 Jun; 18(2):108-12. PubMed ID: 20610933 [TBL] [Abstract][Full Text] [Related]
48. Successful treatment of a left ventricular assist device infection with daptomycin non-susceptible methicillin-resistant Staphylococcus aureus: case report and review of the literature. Levy DT; Steed ME; Rybak MJ; Guo Y; Gialanella P; Hanau L; Muggia V; Ostrowsky B Transpl Infect Dis; 2012 Oct; 14(5):E89-96. PubMed ID: 22931050 [TBL] [Abstract][Full Text] [Related]
49. Molecular Characteristics of Li T; Lu H; Wang X; Gao Q; Dai Y; Shang J; Li M Front Cell Infect Microbiol; 2017; 7():127. PubMed ID: 28469994 [No Abstract] [Full Text] [Related]
50. Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan. Naimi HM; Rasekh H; Noori AZ; Bahaduri MA BMC Infect Dis; 2017 Nov; 17(1):737. PubMed ID: 29187146 [TBL] [Abstract][Full Text] [Related]
53. Ceftaroline in the treatment of concomitant methicillin-resistant and daptomycin-non-susceptible Staphylococcus aureus infective endocarditis and osteomyelitis: case report. Jongsma K; Joson J; Heidari A J Antimicrob Chemother; 2013 Jun; 68(6):1444-5. PubMed ID: 23341127 [No Abstract] [Full Text] [Related]
54. Isolation and first draft genome sequence of a linezolid-dependent García-Angulo VA; Herve B; Melo J; Sanhueza C; la Fuente S; Aguirre LL; Baysdorfer C; Ulloa MT Future Microbiol; 2020 Aug; 15():1123-1129. PubMed ID: 32954844 [No Abstract] [Full Text] [Related]
55. Development of a mouse model of induced Staphylococcus aureus infective endocarditis. Gibson GW; Kreuser SC; Riley JM; Rosebury-Smith WS; Courtney CL; Juneau PL; Hollembaek JM; Zhu T; Huband MD; Brammer DW; Brieland JK; Sulavik MC Comp Med; 2007 Dec; 57(6):563-9. PubMed ID: 18246868 [TBL] [Abstract][Full Text] [Related]
56. In vitro and in vivo synergistic activities of linezolid combined with subinhibitory concentrations of imipenem against methicillin-resistant Staphylococcus aureus. Jacqueline C; Navas D; Batard E; Miegeville AF; Le Mabecque V; Kergueris MF; Bugnon D; Potel G; Caillon J Antimicrob Agents Chemother; 2005 Jan; 49(1):45-51. PubMed ID: 15616274 [TBL] [Abstract][Full Text] [Related]
57. Whole-genome sequencing for detecting linezolid resistance in a patient with persistent methicillin-resistant Staphylococcus aureus infection during linezolid exposure. Wu D; Yan B; Yang X; Ji S; Sun L; Wang H; Shi K; Wei L; Chen Y; Yu Y Int J Antimicrob Agents; 2020 Jan; 55(1):105819. PubMed ID: 31600555 [No Abstract] [Full Text] [Related]